These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 25045812

  • 1. Improving the Th1 cellular efficacy of the lead Yersinia pestis rF1-V subunit vaccine using SA-4-1BBL as a novel adjuvant.
    Dinc G, Pennington JM, Yolcu ES, Lawrenz MB, Shirwan H.
    Vaccine; 2014 Sep 03; 32(39):5035-40. PubMed ID: 25045812
    [Abstract] [Full Text] [Related]

  • 2. Robust Th1 cellular and humoral responses generated by the Yersinia pestis rF1-V subunit vaccine formulated to contain an agonist of the CD137 pathway do not translate into increased protection against pneumonic plague.
    Bowen W, Batra L, Pulsifer AR, Yolcu ES, Lawrenz MB, Shirwan H.
    Vaccine; 2019 Sep 10; 37(38):5708-5716. PubMed ID: 31416643
    [Abstract] [Full Text] [Related]

  • 3. A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model.
    Gregg KA, Harberts E, Gardner FM, Pelletier MR, Cayatte C, Yu L, McCarthy MP, Marshall JD, Ernst RK.
    Vaccine; 2018 Jun 27; 36(28):4023-4031. PubMed ID: 29861179
    [Abstract] [Full Text] [Related]

  • 4. A novel adjuvant, a mixture of alum and the general opioid antagonist naloxone, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine.
    Jazani NH, Sohrabpour M, Mazloomi E, Shahabi S.
    FEMS Immunol Med Microbiol; 2011 Feb 27; 61(1):54-62. PubMed ID: 21054579
    [Abstract] [Full Text] [Related]

  • 5. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
    Song P, He S, Zhou A, Lv G, Guo J, Zhou J, Han Y, Zhou H, Hao Z, Cong H.
    BMC Infect Dis; 2017 Jan 05; 17(1):19. PubMed ID: 28056837
    [Abstract] [Full Text] [Related]

  • 6. Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation.
    Zhang W, Song X, Zhai L, Guo J, Zheng X, Zhang L, Lv M, Hu L, Zhou D, Xiong X, Yang W.
    Front Immunol; 2022 Jan 05; 13():793382. PubMed ID: 35154110
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection.
    Jazani NH, Parsania S, Sohrabpour M, Mazloomi E, Karimzad M, Shahabi S.
    Immunobiology; 2011 Jun 05; 216(6):744-51. PubMed ID: 21093956
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
    Brown TH, David J, Acosta-Ramirez E, Moore JM, Lee S, Zhong G, Hancock RE, Xing Z, Halperin SA, Wang J.
    Vaccine; 2012 Jan 05; 30(2):350-60. PubMed ID: 22075089
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED, Flick-Smith HC, Waters E, Miller J, Hodgson I, Le Butt CS, Hill J.
    Microb Pathog; 2007 Jan 05; 42(1):11-21. PubMed ID: 17107769
    [Abstract] [Full Text] [Related]

  • 17. Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.
    Bielinska AU, O'Konek JJ, Janczak KW, Baker JR.
    Vaccine; 2016 Jul 25; 34(34):4017-24. PubMed ID: 27317451
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Poly(I:C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boosting.
    Chuai X, Chen H, Wang W, Deng Y, Wen B, Ruan L, Tan W.
    PLoS One; 2013 Jul 25; 8(1):e54126. PubMed ID: 23335993
    [Abstract] [Full Text] [Related]

  • 20. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
    Verma V, Tan W, Puth S, Cho KO, Lee SE, Rhee JH.
    J Transl Med; 2016 May 17; 14(1):135. PubMed ID: 27184355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.